These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16300455)

  • 1. After the diagnosis: adherence and persistence with hypertension therapy.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S395-9. PubMed ID: 16300455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and quality of life in ARB-treated patients.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S392-4. PubMed ID: 16300454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
    Grant RW; Singer DE; Meigs JB
    Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Queen Mary Utilization of Antihypertensive Drugs Study: side-effects of antihypertensive drugs.
    Cheung BM; Wong YL; Lau CP
    J Clin Pharm Ther; 2005 Aug; 30(4):391-9. PubMed ID: 15985053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive medication adherence in the Department of Veterans Affairs.
    Siegel D; Lopez J; Meier J
    Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.
    Burnier M
    Am J Hypertens; 2006 Nov; 19(11):1190-6. PubMed ID: 17070434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Now or never: optimal antihypertensive therapy in the elderly.
    Prisant LM
    Prev Cardiol; 2008; 11(4):201-9. PubMed ID: 19476572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular consequences of poor compliance to antihypertensive therapy.
    Grassi G; Seravalle G; Mancia G
    Blood Press; 2011 Aug; 20(4):196-203. PubMed ID: 21299436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
    BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
    White WB
    Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of efficacy and safety of hypertension treatment with original angiotensin-converting enzyme inhibitors: the comparison of original and generic formulations].
    Szczotka B; Jaźwińska-Tarnawska E; Wedlarski R; Łapiński Ł; Wiela-Hojeńska A
    Pol Merkur Lekarski; 2013 Mar; 34(201):140-4. PubMed ID: 23700822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin receptor blockers: impact on costs of care.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance--and improving it--in hypertension.
    Elliott WJ
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):56-61. PubMed ID: 12971594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
    Taira DA; Wong KS; Frech-Tamas F; Chung RS
    Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs.
    Volpe M; Tocci G
    J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.